as on September 17, 2025 at 1:29 am IST
Day's Low
Day's High
0.86%
Downside
0.85%
Upside
52 Week's Low
52 Week's High
36.14%
Downside
4.91%
Upside
Check Incyte Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$16.4B
EPS (TTM)
6.078
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.07%
PE Ratio (TTM)
19.83
Industry PE ratio
16.65525641025641
P/B Ratio
19.8345
PEG Ratio
0.1251
EBITDA
1.1B
Revenue (TTM)
4.6B
Profit Margin
18.99%
Return On Equity TTM
24.30%
Track how Incyte Corporation P/E has moved over time to understand its valuation trends.
Incyte Corporation in the last 5 years
Lowest (12.11x)
June 30, 2025
Industry (16.66x)
September 17, 2025
Today (19.83x)
September 17, 2025
Highest (67.12x)
September 30, 2024
Today’s Price to Earnings Ratio: 19.83x
Compare market cap, revenue, PE, and other key metrics of Incyte Corporation with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $16.4B | -7.21% | 19.83 | 18.99% | |
BUY | $60.5B | 252.04% | -505.15 | -12.96% | |
NA | $39.0B | NA | NA | -3.89% | |
BUY | $100.3B | 44.17% | 27.85 | 31.86% | |
BUY | $59.6B | 1.78% | 14.1 | 31.37% |
The Incyte Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Incyte Corporation investment value today
Current value as on today
₹1,31,121
Returns
₹31,121
(+31.12%)
Returns from Incyte Corporation Stock
₹26,253 (+26.25%)
Dollar Returns*
₹4,867 (+4.87%)
Based on 29 analysts
55.17%
Buy
44.83%
Hold
0.00%
Sell
Based on 29 analysts, 55.17% of analysts recommend a 'BUY' rating for Incyte Corporation. Average target price of $81.55
Get share price movements and forecasts by analysts on Incyte Corporation.
What analysts predicted
-2.84%DOWNSIDE
Target Price
$81.55
Current Price
$83.87
Analyzed by
29 Analysts
Target
$81.55
Incyte Corporation target price $81.55, a slight downside of -2.84% compared to current price of $83.87. According to 29 analysts rating.
Search interest for Incyte Corporation Stock has increased by 242% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:242% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 22 August
Fri, 07:09 PM
-Eli Lilly and Incyte's Olumiant approved for rheumatoid arthritis and alopecia areata, generating $475.2 million in sales.
Fri, 09:38 PM
-Incyte updates clinical study on ruxolitinib for myelofibrosis, aiming to establish a safe starting dose.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 2 quarters, 158.20M → 404.99M (in $), with an average increase of 60.9% per quarter
Revenue Rich
Revenue is up for the last 2 quarters, 1.05B → 1.21B (in $), with an average increase of 13.4% per quarter
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 41.8%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 94.6%
Price Dip
In the last 7 days, INCY stock has moved down by -2.7%
Organisation | Incyte Corporation |
Headquarters | 1801 Augustine Cut-Off, Wilmington, DE, United States, 19803 |
Industry | Health Technology |
CEO | Mr. Herve Hoppenot |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Pablo J. Cagnoni M.D., Ph.D. | President and Head of Research & Development |
Ms. Christiana Stamoulis M.B.A. | Executive VP & CFO |
Mr. Herve Hoppenot | Advisor to CEO & Director |
Dr. Steven H. Stein M.D. | Executive VP & Chief Medical Officer |
Mr. William Meury | CEO, President & Director |
Mr. Thomas Tray | VP of Finance, Chief Accounting Officer & Controller |
Greg Shertzer | Senior Director of Investor Relations |
Mr. Michael James Morrissey | Executive VP & Head of Global Technical Operations |
Ms. Sheila A. Denton J.D. | Executive VP, General Counsel & Corporate Secretary |
Ms. Pamela M. Murphy | Vice President of Investor Relations & Corporate Communications |
Incyte Corporation share price today is $83.87 as on at the close of the market. Incyte Corporation share today touched a day high of $84.58 and a low of $83.15.
Incyte Corporation share touched a 52 week high of $87.99 on and a 52 week low of $53.56 on . Incyte Corporation stock price today i.e. is closed at $83.87,which is 4.68% down from its 52 week high and 56.59% up from its 52 week low.
Incyte Corporation market capitalisation is $0.02T as on .
Indian investors can start investing in Incyte Corporation (INCY) shares with as little as ₹88.042 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Incyte Corporation stock (as per the Rupee-Dollar exchange rate as on ).
Based on Incyte Corporation share’s latest price of $83.87 as on September 17, 2025 at 1:29 am IST, you will get 0.1192 shares of Incyte Corporation. Learn more about
fractional shares .
Incyte Corporation stock has given -7.21% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?